Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1980 1
1984 1
1990 1
1993 1
1995 1
1996 1
1998 5
1999 3
2001 10
2002 6
2003 8
2004 15
2005 7
2006 16
2007 20
2008 26
2009 29
2010 37
2011 45
2012 43
2013 33
2014 59
2015 43
2016 47
2017 39
2018 48
2019 44
2020 40
Text availability
Article attribute
Article type
Publication date

Search Results

556 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis E virus infection.
Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, Dalton HR. Kamar N, et al. Among authors: wedemeyer h. Nat Rev Dis Primers. 2017 Nov 16;3:17086. doi: 10.1038/nrdp.2017.86. Nat Rev Dis Primers. 2017. PMID: 29154369 Review.
The role of zinc in liver cirrhosis.
Grüngreiff K, Reinhold D, Wedemeyer H. Grüngreiff K, et al. Among authors: wedemeyer h. Ann Hepatol. 2016 Jan-Feb;15(1):7-16. doi: 10.5604/16652681.1184191. Ann Hepatol. 2016. PMID: 26626635 Free article. Review.
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.
Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, Davis JL, Hughes MS, Heller T, ElGindi M, Uppala A, Korangy F, Kleiner DE, Figg WD, Venzon D, Steinberg SM, Venkatesan AM, Krishnasamy V, Abi-Jaoudeh N, Levy E, Wood BJ, Greten TF. Duffy AG, et al. Among authors: wedemeyer h. J Hepatol. 2017 Mar;66(3):545-551. doi: 10.1016/j.jhep.2016.10.029. Epub 2016 Nov 2. J Hepatol. 2017. PMID: 27816492 Free PMC article. Clinical Trial.
Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta.
Deterding K, Wedemeyer H. Deterding K, et al. Among authors: wedemeyer h. AIDS Rev. 2019;21(3):126-134. doi: 10.24875/AIDSRev.19000080. AIDS Rev. 2019. PMID: 31532397 Review.
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
Zeuzem S, Foster GR, Wang S, Asatryan A, Gane E, Feld JJ, Asselah T, Bourlière M, Ruane PJ, Wedemeyer H, Pol S, Flisiak R, Poordad F, Chuang WL, Stedman CA, Flamm S, Kwo P, Dore GJ, Sepulveda-Arzola G, Roberts SK, Soto-Malave R, Kaita K, Puoti M, Vierling J, Tam E, Vargas HE, Bruck R, Fuster F, Paik SW, Felizarta F, Kort J, Fu B, Liu R, Ng TI, Pilot-Matias T, Lin CW, Trinh R, Mensa FJ. Zeuzem S, et al. Among authors: wedemeyer h. N Engl J Med. 2018 Jan 25;378(4):354-369. doi: 10.1056/NEJMoa1702417. N Engl J Med. 2018. PMID: 29365309 Free article. Clinical Trial.
Hepatitis delta virus.
Hughes SA, Wedemeyer H, Harrison PM. Hughes SA, et al. Among authors: wedemeyer h. Lancet. 2011 Jul 2;378(9785):73-85. doi: 10.1016/S0140-6736(10)61931-9. Epub 2011 Apr 20. Lancet. 2011. PMID: 21511329 Review.
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy.
Yurdaydin C, Abbas Z, Buti M, Cornberg M, Esteban R, Etzion O, Gane EJ, Gish RG, Glenn JS, Hamid S, Heller T, Koh C, Lampertico P, Lurie Y, Manns M, Parana R, Rizzetto M, Urban S, Wedemeyer H; Hepatitis Delta International Network (HDIN). Yurdaydin C, et al. Among authors: wedemeyer h. J Hepatol. 2019 May;70(5):1008-1015. doi: 10.1016/j.jhep.2018.12.022. Epub 2018 Dec 27. J Hepatol. 2019. PMID: 30982526 Review.
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.
Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, Petrachenkova M, Lehr T, Lempp FA, Wedemeyer H, Haag M, Schwab M, Haefeli WE, Blank A, Urban S. Bogomolov P, et al. Among authors: wedemeyer h. J Hepatol. 2016 Sep;65(3):490-8. doi: 10.1016/j.jhep.2016.04.016. Epub 2016 Apr 27. J Hepatol. 2016. PMID: 27132170 Clinical Trial.
[Major depression and liver disease: the role of microbiome and inflammation].
Kahl KG, Krüger T, Eckermann G, Wedemeyer H. Kahl KG, et al. Among authors: wedemeyer h. Fortschr Neurol Psychiatr. 2019 Feb;87(1):12-21. doi: 10.1055/s-0043-123068. Epub 2018 Feb 28. Fortschr Neurol Psychiatr. 2019. PMID: 29490382 Review. German.
Betablocker helfen bei Leberzirrhose.
Kleefisch M, Lange C, Wedemeyer H. Kleefisch M, et al. Among authors: wedemeyer h. MMW Fortschr Med. 2019 Nov;161(20):39. doi: 10.1007/s15006-019-1119-y. MMW Fortschr Med. 2019. PMID: 31773605 Review. German. No abstract available.
556 results
Jump to page
Feedback